内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Bunka Christopher. Officer active across 2 companies, notably Lexaria Bioscience Corp.. Aggregated, 16 reports have been published. Breakdown: 13 buys · 0 sell. Total volume traded: €57k. Activity tracked since 12 October 2022. The latest transaction was filed on 17 March 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bunka Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
100,000 股0common sharesSEC:0001103780-26-000001:0
15,600 股@ US$0.921512.2% 占其流量common sharesSEC:0001348362-25-000016:0
100,000 股0Restricted Stock AwardSEC:0001348362-25-000001:0
21,900 股@ US$1.98850.0% 占其流量common sharesSEC:0001855763-22-000019:0
21,900 股@ US$1.98850.0% 占其流量common sharesSEC:0001855763-22-000014:0
2,000 股Common SharesSEC:0001103780-16-000079:0
5,000 股Common SharesSEC:0001103780-16-000079:1
5,000 股Common SharesSEC:0001103780-16-000078:0
10,000 股Common SharesSEC:0001103780-16-000078:1
5,000 股Common SharesSEC:0001103780-16-000078:2
12,500 股Common SharesSEC:0001103780-16-000078:3
3,990 股Common SharesSEC:0001103780-16-000077:0
5,000 股Common SharesSEC:0001103780-16-000077:1
5,000 股Common SharesSEC:0001103780-16-000076:0
10,000 股Common SharesSEC:0001103780-16-000076:1
5,000 股Common SharesSEC:0001103780-16-000076:2
About Bunka Christopher
BUNKA CHRISTOPHER is linked to LEXARIA CORP., where he is CEO, and to Lexaria Bioscience Corp., where he is Director. He has 16 filings, and the sampled recent filings cover the period from 2016-01-06 to 2026-03-18, with EUR 57,292 of purchases and EUR 0 of sales, and the modal transaction nature is Acquisition.